We are live on ! Find out more
LA

Linden Advisors Portfolio holdings

AUM $17.9B
1-Year Est. Return 1.72%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+1.72%
3 Year Est. Return
+2.79%
5 Year Est. Return
+3.4%
10 Year Est. Return
+25.58%
AUM
$12.1B
AUM Growth
+$181M
Cap. Flow
-$9.97B
Cap. Flow %
-82.63%
Top 10 Hldgs %
26.31%
Holding
305
New
43
Increased
3
Reduced
4
Closed
41

Sector Composition

Rank Sector Weight
1 Financials 0.88%
2 Technology 0.36%
3 Energy 0.31%
4 Industrials 0%
5 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRLW
101
DELISTED
Israel Acquisitions Corp Warrant
ISRLW
$11.3K ﹤0.01%
250,000
AILEW
102
DELISTED
iLearningEngines, Inc. Warrant
AILEW
$10.7K ﹤0.01%
649,950
ABVEW
103
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$10.5K ﹤0.01%
466,193
PPYAW
104
DELISTED
Papaya Growth Opportunity Corp. I Warrant
PPYAW
$10.4K ﹤0.01%
400,000
ESHAR
105
DELISTED
ESH Acquisition Corp Right
ESHAR
$9.13K ﹤0.01%
100,000
DISTR
106
DELISTED
Distoken Acquisition Corporation Right
DISTR
$9.12K ﹤0.01%
75,000
LFLYW
107
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$5.76K ﹤0.01%
339,123
ZCARW
108
DELISTED
Zoomcar Holdings, Inc. Warrants
ZCARW
$5.74K ﹤0.01%
375,000
ICUCW
109
SeaStar Medical Holding Corp Warrant
ICUCW
$413K
$5.45K ﹤0.01%
218,073
HOFVW
110
DELISTED
Hall of Fame Resort & Entertainment Company Warrant
HOFVW
$5.16K ﹤0.01%
991,928
HYMCW
111
DELISTED
Hycroft Mining Holding Corporation Warrant
HYMCW
$4.3K ﹤0.01%
753,819
BNZIW icon
112
Banzai International Warrant
BNZIW
$131K
$3.89K ﹤0.01%
335,465
CAPTW
113
DELISTED
Captivision Inc Warrant
CAPTW
$3.8K ﹤0.01%
249,999
CLRCW
114
DELISTED
ClimateRock Warrant
CLRCW
$3.75K ﹤0.01%
149,999
REVBW icon
115
Revelation Biosciences Warrant
REVBW
$9.6K
$2.51K ﹤0.01%
338,110
CEROW
116
DELISTED
CERo Therapeutics Warrants
CEROW
$2.3K ﹤0.01%
249,999
LFLY
117
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
$2.12K ﹤0.01%
+1,500
New +$2.48K
DISTW
118
DELISTED
Distoken Acquisition Corporation Warrant
DISTW
$1.4K ﹤0.01%
74,135
UKOMW
119
DELISTED
Ucommune International Ltd Warrant
UKOMW
$1.35K ﹤0.01%
207,680
ALCY
120
DELISTED
Alchemy Investments Acquisition Corp 1
ALCY
-500,000
Closed -$5.44M
ANSCU
121
Agriculture & Natural Solutions Acquisition Corp Unit
ANSCU
-500,000
Closed -$5.3M
BOWN
122
DELISTED
Bowen Acquisition Corp
BOWN
-250,000
Closed -$2.69M
CLBR.U
123
DELISTED
Colombier Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CLBR.U
-650,000
Closed -$6.75M
ESHA
124
DELISTED
ESH Acquisition Corp
ESHA
-100,000
Closed -$1.06M
SVIIR
125
DELISTED
Spring Valley Acquisition Corp II Rights
SVIIR
-600,000
Closed -$60.4K

Similar funds

Linden Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Linden Advisors held 305 positions worth $12.1B, up 1.5% from $11.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Linden Advisors withdrew a net $9.97B in Q4 2024, closing 41 positions and reducing 4 holdings. Its most notable exit was EQV Ventures Acquisition Corp Units, an estimated $31.4M position sold in full.

By sector, the portfolio is most concentrated in Financials at 0.88% of assets, up from 0.3% a quarter earlier, followed by Technology and Energy.

Against the trend, Linden Advisors opened a new position in Presidio Production Co worth $31.6M.

  • Linden Advisors's largest Q4 2024 buy was Presidio Production Co: 3,165,000 shares worth $31.6M.
  • Linden Advisors added most to SK Growth Opportunities Corporation Class A Common Stock in Q4 2024, an estimated $4.03M increase.
  • Linden Advisors's biggest Q4 2024 reduction was BrightSpring Health Services Unit, cutting an estimated $81.8M.
  • Linden Advisors fully exited EQV Ventures Acquisition Corp Units in Q4 2024, selling an estimated $31.4M.
  • Linden Advisors's ten largest holdings make up 26% of its $12.1B portfolio in Q4 2024.
  • Linden Advisors opened 43 new positions and closed 41 in Q4 2024.
  • Linden Advisors's portfolio value rose 1.5% quarter-over-quarter to $12.1B.

Based on Linden Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.